 Mahasweta Girgenrath PhD
| Title | Associate Professor |
|---|
| Institution | University of Massachusetts Medical School |
|---|
| Department | Neurology |
|---|
| Address | University of Massachusetts Medical School
55 Lake Avenue North
Worcester MA 01655
|
|---|
| vCard | Download vCard |
|---|
|
|
|
|
| Institution | UMMS - School of Medicine |
|---|
| Department | Neurology |
|---|
|
|
|---|
|
 Biography | Annamalai University, Chidambaram, TN, India | BED | | Biology & English | | Delhi University, New Delhi, DL, India | BS | | Biology | | Northeastern University, Boston, MA, United States | PHD | | Biology |
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Accorsi A, Cramer ML, Girgenrath M. Fibrogenesis in LAMA2-Related Muscular Dystrophy Is a Central Tenet of Disease Etiology. Front Mol Neurosci. 2020; 13:3. PMID: 32116541.
-
Gordish-Dressman H, Willmann R, Pazze LD, Kreibich A, van Putten M, Heydemann A, Bogdanik L, Lutz C, Davies K, Demonbruen AR, Duan D, Elsey D, Fukada SI, Girgenrath M, Gonzalez JP, Grounds MD, Nichols A, Partridge T, Passini M, Sanarica F, Schnell FJ, Wells DJ, Yokota T, Young CS, Zhong Z, Spurney C, Spencer M, De Luca A, Nagaraju K, Aartsma-Rus A. "Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic First Workshop Report: Examining current findings and opportunities around the emerging D2.B10-Dmdmdx/J (D2/mdx) model in context of the classic C57BL/10ScSn-Dmdmdx/J (Bl10/mdx). J Neuromuscul Dis. 2018 Sep 03. PMID: 30198876.
-
Willmann R, Gordish-Dressman H, Meinen S, Rüegg MA, Yu Q, Nagaraju K, Kumar A, Girgenrath M, Coffey CBM, Cruz V, Van Ry PM, Bogdanik L, Lutz C, Rutkowski A, Burkin DJ. Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-a2 Related Congenital Muscular Dystrophy. J Neuromuscul Dis. 2017 May 24. PMID: 28550268.
-
Accorsi A, Kumar A, Rhee Y, Miller A, Girgenrath M. IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy. Hum Mol Genet. 2016 Oct 24. PMID: 27798092.
-
Clark AL, Maruyama S, Sano S, Accorsi A, Girgenrath M, Walsh K, Naya FJ. miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy. PLoS One. 2016; 11(3):e0151515. PMID: 26999812.
-
Vohra R, Accorsi A, Kumar A, Walter G, Girgenrath M. Magnetic Resonance Imaging Is Sensitive to Pathological Amelioration in a Model for Laminin-Deficient Congenital Muscular Dystrophy (MDC1A). PLoS One. 2015; 10(9):e0138254. PMID: 26379183.
-
Kumar A, Accorsi A, Rhee Y, Girgenrath M. Do's and don'ts in the preparation of muscle cryosections for histological analysis. J Vis Exp. 2015; (99):e52793. PMID: 26066009.
-
Accorsi A, Mehuron T, Kumar A, Rhee Y, Girgenrath M. Integrin dysregulation as a possible driver of matrix remodeling in Laminin-deficient congenital muscular dystrophy (MDC1A). J Neuromuscul Dis. 2015; 2(1):51-61. PMID: 28198706.
-
Mehuron T, Kumar A, Duarte L, Yamauchi J, Accorsi A, Girgenrath M. Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy. Skelet Muscle. 2014; 4:14. PMID: 25075272.
-
Yamauchi J, Kumar A, Duarte L, Mehuron T, Girgenrath M. Triggering regeneration and tackling apoptosis: a combinatorial approach to treating congenital muscular dystrophy type 1 A. Hum Mol Genet. 2013 Nov 1; 22(21):4306-17. PMID: 23773998.
-
Rutkowski A, Bönnemann C, Brown S, Thorsteinsdóttir S, Dominov J, Ruegg MA, Matter ML, Guttridge D, Crosbie-Watson RH, Kardon G, Nagaraju K, Girgenrath M, Burkin DJ. Report on the Myomatrix Conference April 22-24, 2012, University of Nevada, Reno, Nevada, USA. Neuromuscul Disord. 2013 Feb; 23(2):188-91. PMID: 22800409.
-
Kumar A, Yamauchi J, Girgenrath T, Girgenrath M. Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A. Hum Mol Genet. 2011 Jun 15; 20(12):2333-43. PMID: 21441569.
-
Beermann ML, Ardelt M, Girgenrath M, Miller JB. Prdm1 (Blimp-1) and the expression of fast and slow myosin heavy chain isoforms during avian myogenesis in vitro. PLoS One. 2010 Apr 01; 5(4):e9951. PMID: 20376350.
-
Girgenrath M, Beermann ML, Vishnudas VK, Homma S, Miller JB. Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy. Ann Neurol. 2009 Jan; 65(1):47-56. PMID: 19086074.
-
Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SA, Winkles JA, Michaelson JS, Allaire N, Schneider P, Scott ML, Hsu YM, Yagita H, Flavell RA, Miller JB, Burkly LC, Zheng TS. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J. 2006 Dec 13; 25(24):5826-39. PMID: 17124496.
-
Miller JB, Girgenrath M. The role of apoptosis in neuromuscular diseases and prospects for anti-apoptosis therapy. Trends Mol Med. 2006 Jun; 12(6):279-86. PMID: 16650805.
-
Girgenrath M, Kostek CA, Miller JB. Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations. BMC Neurol. 2005 Apr 07; 5(1):7. PMID: 15817132.
-
Girgenrath M, Dominov JA, Kostek CA, Miller JB. Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J Clin Invest. 2004 Dec; 114(11):1635-9. PMID: 15578095.
-
Nowak JA, Malowitz J, Girgenrath M, Kostek CA, Kravetz AJ, Dominov JA, Miller JB. Immortalization of mouse myogenic cells can occur without loss of p16INK4a, p19ARF, or p53 and is accelerated by inactivation of Bax. BMC Cell Biol. 2004 Jan 08; 5:1. PMID: 14711384.
-
Girgenrath M, Marsh RL. Season and testosterone affect contractile properties of fast calling muscles in the gray tree frog Hyla chrysoscelis. Am J Physiol Regul Integr Comp Physiol. 2003 Jun; 284(6):R1513-20. PMID: 12595277.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2003 | 1 | | 2004 | 2 | | 2005 | 1 | | 2006 | 2 | | 2009 | 1 | | 2010 | 1 | | 2011 | 1 | | 2012 | 1 | | 2013 | 1 | | 2014 | 1 | | 2015 | 3 | | 2016 | 2 | | 2017 | 1 | | 2018 | 1 | | 2020 | 1 |
To return to the timeline, click here.
For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
|
Girgenrath's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|